Your browser doesn't support javascript.
loading
Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy.
Tess, David A; Maurer, Tristan S; Li, Zhenhong; Bulawa, Christine; Fleming, James; Moody, Amy T.
Affiliation
  • Tess DA; Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USA.
  • Maurer TS; Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USA.
  • Li Z; Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USA.
  • Bulawa C; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA, USA.
  • Fleming J; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA, USA.
  • Moody AT; Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USA.
Amyloid ; 30(2): 208-219, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36399070
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid Neuropathies, Familial / Cardiomyopathies Type of study: Prognostic_studies Limits: Humans Language: En Journal: Amyloid Journal subject: BIOQUIMICA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid Neuropathies, Familial / Cardiomyopathies Type of study: Prognostic_studies Limits: Humans Language: En Journal: Amyloid Journal subject: BIOQUIMICA Year: 2023 Document type: Article Affiliation country: Country of publication: